A suggested positive control is SK-N-SH cell lysate. PA5-20498 can be used with blocking peptide PEP-0618. BAP3 was initially identified through interaction in a yeast two-hybrid system with the brain-specific angiogenesis inhibitor 1, a p53-target gene